04/29/2024
5:01 AM | BioXcel Therapeutics (Filer)
| Form DEF 14A | |
04/29/2024
5:03 AM | BioXcel Therapeutics (Filer)
| Form DEFA14A | |
04/22/2024
6:10 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/19/2024
6:01 AM | BioXcel Therapeutics (Filer)
| Form PRE 14A | |
04/10/2024
6:05 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/08/2024
6:30 PM | BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
6:31 PM | BioXcel Therapeutics (Issuer)
Wiley Matthew T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
04/08/2024
6:32 PM | BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
6:32 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
6:32 PM | BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
6:30 PM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
1:50 PM | BioXcel Therapeutics (Subject)
Wiley Matthew T. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024
1:01 PM | BioXcel Therapeutics (Subject)
Mehta Vimal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024
12:20 PM | BioXcel Therapeutics (Subject)
Yocca Frank (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024
12:40 PM | BioXcel Therapeutics (Subject)
O'Neill Vincent (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/03/2024
3:55 PM | BioXcel Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/25/2024
3:05 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2024
6:15 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2024
11:45 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/09/2024
7:35 AM | BioXcel Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
02/08/2024
4:27 PM | BioXcel Therapeutics (Filer)
| Form 424B5 | |
02/08/2024
6:08 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2024
6:27 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
BioXcel Therapeutics (Subject)
| Form SC 13G/A | |
01/22/2024
11:15 PM | BioXcel Therapeutics (Filer)
| Form EFFECT | |
12/18/2023
3:52 PM | BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
3:54 PM | BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
3:55 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
3:57 PM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
3:47 PM | BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
6:22 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2023
6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2023
6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
11:15 PM | BioXcel Therapeutics (Filer)
| Form EFFECT | |
11/13/2023
10:59 AM | BioXcel Therapeutics (Filer)
| Form RW WD | |
11/13/2023
9:23 AM | BioXcel Therapeutics (Filer)
| Form RW | |
11/02/2023
5:01 AM | BioXcel Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/19/2023
3:48 PM | BioXcel Holdings, Inc. (Filed by)
BioXcel Therapeutics (Subject)
| Form SC 13G/A | |
10/13/2023
3:01 PM | BioXcel Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
10/10/2023
8:09 AM | BioXcel Therapeutics (Subject)
FIL Ltd (Filed by)
| Form SC 13G/A | |
10/10/2023
6:06 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
The A.I. story nobody is telling you (Read ASAP) (Ad) There's been a lot of buzz surrounding A.I. over the past year...
Most of it is just hype and speculation.
But there's one recent A.I. development you NEED to hear about... Click here to see Louis' new video for yourself. |
10/04/2023
6:05 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2023
4:07 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2023
10:21 AM | BioXcel Therapeutics (Subject)
Mueller Family 2010 Irrevocable Trust (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2023
9:55 AM | BioXcel Therapeutics (Subject)
MUELLER PETER (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2023
10:15 AM | BioXcel Therapeutics (Subject)
Peter Mueller 2018 Irrevocable Family Trust (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/19/2023
7:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/18/2023
3:47 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2023
3:47 PM | BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2023
3:48 PM | BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2023
3:49 PM | BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2023
3:49 PM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2023
6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/07/2023
6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/22/2023
6:01 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
8:11 AM | BioXcel Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2023
6:20 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2023
3:17 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/29/2023
5:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2023
3:58 PM | BioXcel Therapeutics (Issuer)
Laumas Sandeep (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
3:59 PM | BioXcel Therapeutics (Issuer)
MILLER MICHAEL PATRICK (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
4:01 PM | BioXcel Therapeutics (Issuer)
MUELLER PETER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
4:02 PM | BioXcel Therapeutics (Issuer)
Bray June (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
11:28 AM | BioXcel Therapeutics (Subject)
Mueller Family 2010 Irrevocable Trust (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2023
11:20 AM | BioXcel Therapeutics (Subject)
Peter Mueller 2018 Irrevocable Family Trust (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2023
11:05 AM | BioXcel Therapeutics (Subject)
MUELLER PETER (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/16/2023
5:42 PM | BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
5:44 PM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
5:46 PM | BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
5:36 PM | BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
5:40 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
1:13 PM | BioXcel Therapeutics (Subject)
Mehta Vimal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/24/2023
3:37 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2023
2:26 PM | BioXcel Therapeutics (Subject)
Mehta Vimal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2023
7:29 PM | BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2023
7:32 PM | BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2023
7:33 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2023
8:54 AM | BioXcel Therapeutics (Subject)
Rodriguez Javier (Reporting)
| Form 144/A | |
05/15/2023
11:04 AM | BioXcel Therapeutics (Subject)
Steinhart Richard I (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2023
9:52 AM | BioXcel Therapeutics (Subject)
Rodriguez Javier (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/08/2023
7:30 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
